← Back to Search

Critically ill adults for Oxygen Consumption (TOUCAN-1 Trial)

N/A
Recruiting
Led By Aaron S Hess, MD, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 20 minutes
Awards & highlights

TOUCAN-1 Trial Summary

The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins. Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.

TOUCAN-1 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of digital pulse oximetry
Accuracy of jugular pulse oximetry

TOUCAN-1 Trial Design

1Treatment groups
Experimental Treatment
Group I: Critically ill adultsExperimental Treatment2 Interventions
Inpatient adults who require internal jugular venous central line and radial arterial line

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,190 Previous Clinical Trials
3,169,577 Total Patients Enrolled
Aaron S Hess, MD, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~25 spots leftby Oct 2024